|
⚲
|
| Keyboard |
| Velan Capital Investment Management LP | |
|---|---|
| Firm | Avego Management LLC |
| Address | 100 North Main Street Suite 301 Alpharetta, GA 30009 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Avego Management LLC | |||||
| Velan Capital Opportunity Fund II LLC | 021-542590 | Executive Officer | 2.4 M | 1.8 M | |
| Velan Capital SPV I LLC | 021-484828 | Executive Officer | 5.5 M | 18.1 M | |
| Velan Capital Master Fund LP | 021-381810 | Executive Officer | 11.7 M | 256.1 M | |
| Velan Capital Offshore Fund Ltd | 021-381810 | Executive Officer | 11.7 M | ||
| Velan Capital Partners LP | 021-381810 | Executive Officer | 11.7 M | 143.9 M | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Alimera Sciences Inc ALIM
Warrants · derivative
|
2024-09-16 | Disposed to issuer | 800,000 | ||
|
Alimera Sciences Inc ALIM
Common Stock
|
2024-09-16 | Disposed to issuer | 9,429,808 | ||
|
Alimera Sciences Inc ALIM
Common Stock
|
2024-09-16 | Disposed to issuer | 4,178,725 | ||
|
Alimera Sciences Inc ALIM
Stock Option (Right to Buy) · derivative
|
2024-09-16 | Disposed to issuer | 50,000 | ||
|
Alimera Sciences Inc ALIM
Stock Option (Right to Buy) · derivative
|
2024-09-16 | Disposed to issuer | 1,825 | ||
|
Jasper Therapeutics Inc JSPR
Common Stock, par value $0.0001 per share
|
2024-02-08 | Buy | 350,000 | $12.95 | 4,532,500 |
|
Alimera Sciences Inc ALIM
Stock Option (Right to Buy) · derivative
|
2023-10-02 | Grant | 50,000 | $0.00 | |
|
Alimera Sciences Inc ALIM
Series B Convertible Preferred Stock · derivative
|
2023-08-15 | Conversion | 7,000 | ||
|
Alimera Sciences Inc ALIM
Common Stock
|
2023-08-15 | Conversion | 2,924,762 | $2.10 | 6,142,000 |
|
Alimera Sciences Inc ALIM
Common Stock
|
2023-08-15 | Conversion | 4,178,725 | $1.70 | 7,103,832 |
|
Alimera Sciences Inc ALIM
Common Stock
|
2023-08-15 | Conversion | 4,845,392 | $1.70 | 8,237,166 |
|
Alimera Sciences Inc ALIM
Series B Convertible Preferred Stock · derivative
|
2023-08-15 | Conversion | 6,000 | ||
|
Alimera Sciences Inc ALIM
Series B Convertible Preferred Stock · derivative
|
2023-08-15 | Conversion | 8,117 | ||
|
Progenics Pharmaceuticals Inc PGNX
Common Stock, $0.0013 par value
|
2019-09-09 | Buy | 72,023 | $4.99 | 359,395 |
|
Progenics Pharmaceuticals Inc PGNX
Common Stock, $0.0013 par value
|
2019-09-04 | Buy | 243,614 | $4.51 | 1,098,699 |
|
Progenics Pharmaceuticals Inc PGNX
Common Stock, $0.0013 par value
|
2019-09-03 | Buy | 277,424 | $4.39 | 1,217,891 |
|
Progenics Pharmaceuticals Inc PGNX
Common Stock, $0.0013 par value
|
2019-08-26 | Buy | 73,230 | $4.30 | 314,889 |
|
Progenics Pharmaceuticals Inc PGNX
Common Stock, $0.0013 par value
|
2019-08-23 | Buy | 130,826 | $4.31 | 563,860 |